DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Sandborn WJ. et al.
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial. 
Gut 2004; 53: 1485-1493  

Download Bibliographical Data

Search in:
Access:
Access: